May 18, 2007 — Hansen Medical Inc. said Thursday it obtained approval in the European Union for its Sensei robotic catheter system and Artisan catheter, which allows the company to begin marketing the system in the EU.

Mountain View, CA,-based Hansen is a developer of robotic technology for control of catheter movement during cardiac procedures.

May 18, 2007 — Inverness Medical Innovations Inc. and Biosite Inc. have announced the companies have entered into a definitive merger agreement under which Inverness will acquire all of Biosite’s outstanding common stock not already owned by Inverness in a cash tender offer for $92.50 per share.

May 18, 2007 — Medicure, a biopharmaceutical company focused on the research, development and commercialization of novel compounds to treat cardiovascular disorders, is developing MC-1 for the treatment of acute ischemia and ischemic reperfusion injury, and has received a Fast Track Designation from the FDA for the drug.

Currently, MC-1 has completed two positive Phase 2 studies, one in angioplasty patients and most recently a 901-patient coronary artery bypass graft (CABG) study, called MEND-CABG.

May 18, 2007 — CoreValve has announced that it has received CE Mark approval of its CoreValve Percutaneous ReValving System for treatment of high-risk patients.

May 18, 2007 — Picture paramedics mobilizing a team of cardiologists and nurses within minutes of arriving at the home of a person who is having a heart attack, simply by pressing a button that sends an electrocardiogram (ECG) over a wireless network. That’s exactly what’s being done at a Newark, NJ, medical center, and it’s dramatically improving the quality of care, according to a study honored as the best abstract presented at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI), May 9–12, 2007.

May 16, 2007 — Boston Scientific Corp. has announced that it has completed enrollment in the European and Intercontinental phases (II and III) of its TAXUS OLYMPIA registry, bringing the total number of current patients to more than 23,000.

The registry is designed to evaluate the safety and performance of the Company's second-generation drug-eluting coronary stent (DES), TAXUS Liberte, in a real-world setting. OLYMPIA is the world's largest DES registry and plans to enroll at least 27,000 patients treated for complex coronary lesions at more than 400 centers worldwide.

May 16, 2007 — Extremely anxious patients with heart disease have been found to be at double the risk of heart attack or death when compared to those with a more relaxed life attitude, reports ANI.

May 16, 2007 — Monebo Technologies Inc. has announced that the CardioBelt Electrode System is now available, following clearance by the FDA.

May 16, 2007 — Stentys has announced that the results of preclinical testing of its bifurcated stent will be reported on Thursday, May 24, 2007, at the "EuroPCR 2007" Cardiovascular Congress in Barcelona, Spain next week as part of the "Innovative Emerging Technologies" program.

Stentys is the first company to develop the next-generation of dedicated drug-eluting stents for treatment of blocked coronary artery bifurcations so that hundreds of thousands of patients might avoid open-chest surgery.

May 15, 2007 — Acorn Cardiovascular has announced that the FDA will consider approval of the CorCap Cardiac Support Device (CSD) based on the successful completion of a prospective confirmatory trial that addresses issues raised by the Medical Device Dispute Resolution Panel and the Circulatory System Devices Panel. The company had completed a 300-patient prospective, randomized pivotal trial and submitted data to the FDA in 2004. However, the two panels voted against approval for the CorCap CSD in December 2006 and June 2005, respectively, citing the need for additional clinical data.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now